Logo image of ACVA

ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

USA - NYSE:ACVA - US00091G1040 - Common Stock

10.12 USD
+0.02 (+0.2%)
Last: 10/3/2025, 8:20:53 PM
10.12 USD
0 (0%)
After Hours: 10/3/2025, 8:20:53 PM
Fundamental Rating

3

Taking everything into account, ACVA scores 3 out of 10 in our fundamental rating. ACVA was compared to 84 industry peers in the Commercial Services & Supplies industry. The financial health of ACVA is average, but there are quite some concerns on its profitability. ACVA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ACVA had negative earnings in the past year.
In the past year ACVA had a positive cash flow from operations.
In the past 5 years ACVA always reported negative net income.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

ACVA has a Return On Assets of -5.65%. This is in the lower half of the industry: ACVA underperforms 66.67% of its industry peers.
The Return On Equity of ACVA (-14.32%) is worse than 63.10% of its industry peers.
Industry RankSector Rank
ROA -5.65%
ROE -14.32%
ROIC N/A
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

ACVA has a Gross Margin of 53.10%. This is amongst the best in the industry. ACVA outperforms 94.05% of its industry peers.
In the last couple of years the Gross Margin of ACVA has grown nicely.
The Profit Margin and Operating Margin are not available for ACVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

4

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACVA has been increased compared to 1 year ago.
Compared to 5 years ago, ACVA has more shares outstanding
Compared to 1 year ago, ACVA has a worse debt to assets ratio.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 1.60, we must say that ACVA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.60, ACVA is doing worse than 61.90% of the companies in the same industry.
ACVA has a debt to FCF ratio of 3.13. This is a good value and a sign of high solvency as ACVA would need 3.13 years to pay back of all of its debts.
ACVA's Debt to FCF ratio of 3.13 is fine compared to the rest of the industry. ACVA outperforms 72.62% of its industry peers.
ACVA has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
ACVA has a Debt to Equity ratio (0.42) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Altman-Z 1.6
ROIC/WACCN/A
WACC8.34%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ACVA has a Current Ratio of 1.59. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
ACVA's Current ratio of 1.59 is in line compared to the rest of the industry. ACVA outperforms 55.95% of its industry peers.
A Quick Ratio of 1.59 indicates that ACVA should not have too much problems paying its short term obligations.
ACVA has a better Quick ratio (1.59) than 65.48% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.02% over the past year.
Looking at the last year, ACVA shows a very strong growth in Revenue. The Revenue has grown by 30.08%.
Measured over the past years, ACVA shows a very strong growth in Revenue. The Revenue has been growing by 42.93% on average per year.
EPS 1Y (TTM)17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)30.08%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%20.59%

3.2 Future

Based on estimates for the next years, ACVA will show a very strong growth in Earnings Per Share. The EPS will grow by 45.81% on average per year.
Based on estimates for the next years, ACVA will show a quite strong growth in Revenue. The Revenue will grow by 19.75% on average per year.
EPS Next Y42.63%
EPS Next 2Y39.74%
EPS Next 3Y40.57%
EPS Next 5Y45.81%
Revenue Next Year21.21%
Revenue Next 2Y20.5%
Revenue Next 3Y20.11%
Revenue Next 5Y19.75%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2 3 4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ACVA is valued a bit cheaper than 65.48% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.23
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

ACVA's earnings are expected to grow with 40.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.74%
EPS Next 3Y40.57%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ACVA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ACV AUCTIONS INC-A

NYSE:ACVA (10/3/2025, 8:20:53 PM)

After market: 10.12 0 (0%)

10.12

+0.02 (+0.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)11-05 2025-11-05
Inst Owners105.31%
Inst Owner Change0%
Ins Owners2.45%
Ins Owner Change-9.89%
Market Cap1.74B
Analysts84
Price Target19.85 (96.15%)
Short Float %6.63%
Short Ratio3.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)29.78%
Min EPS beat(2)23.94%
Max EPS beat(2)35.62%
EPS beat(4)3
Avg EPS beat(4)16.19%
Min EPS beat(4)-9.21%
Max EPS beat(4)35.62%
EPS beat(8)6
Avg EPS beat(8)9.46%
EPS beat(12)10
Avg EPS beat(12)18.85%
EPS beat(16)13
Avg EPS beat(16)15.67%
Revenue beat(2)0
Avg Revenue beat(2)-2.4%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-1.63%
Revenue beat(4)1
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)4.71%
Revenue beat(8)2
Avg Revenue beat(8)-0.44%
Revenue beat(12)4
Avg Revenue beat(12)0.08%
Revenue beat(16)7
Avg Revenue beat(16)1.14%
PT rev (1m)-2.1%
PT rev (3m)-15.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.08%
EPS NY rev (1m)0%
EPS NY rev (3m)6.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.2%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.46
P/FCF 29.23
P/OCF 17.73
P/B 3.88
P/tB 16.87
EV/EBITDA N/A
EPS(TTM)-0.39
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.35
FCFY3.42%
OCF(TTM)0.57
OCFY5.64%
SpS4.11
BVpS2.61
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.65%
ROE -14.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.1%
FCFM 8.43%
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score6
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.13
Debt/EBITDA N/A
Cap/Depr 92.97%
Cap/Sales 5.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z 1.6
F-Score6
WACC8.34%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y42.63%
EPS Next 2Y39.74%
EPS Next 3Y40.57%
EPS Next 5Y45.81%
Revenue 1Y (TTM)30.08%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%20.59%
Revenue Next Year21.21%
Revenue Next 2Y20.5%
Revenue Next 3Y20.11%
Revenue Next 5Y19.75%
EBIT growth 1Y26.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year183.7%
EBIT Next 3Y66.33%
EBIT Next 5Y45.06%
FCF growth 1Y1113.5%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y373.93%
OCF growth 3Y-8.47%
OCF growth 5YN/A